Vista Group International Ltd (VGL)
Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026
Key indicators
| Last close | AUD 2.280 |
|---|---|
| 52-week range | 1.258 – 2.640 |
| Return, 1 month / 3 months | +2.7% / +13.4% |
| Return, 1 year / 3 years | −8.8% / +90.8% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 57.3% |
| Worst drawdown (1 year) | -44.5% |
| Average daily value traded | 0.11M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vista Group International is a software company serving the cinema industry from its base in New Zealand. It supplies cinema operators with management and ticketing systems, point-of-sale software and related data services that help venues run their box offices and understand audience behaviour. Its customers are movie exhibitors and cinema chains in many countries, who use the company's products to manage screenings, admissions and concessions. The business also offers analytics and marketing tools built around cinema audience data.
The shares are listed on the Australian Securities Exchange in Australia under the code VGL, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vista Group International Ltd (VGL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.280 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 201 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.8% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 21.5% | ||
| From 52-week high | -8.8% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.4% | ||
| 6-month return | 50.5% | ||
| 12-month return, skipping the last month | -11.2% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 57.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.5% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.11M AUD | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +2.7% |
| 3 months | +13.4% |
| 6 months | +50.5% |
| 1 year | −8.8% |
| 3 years | +90.8% |
| 5 years | −8.1% |
Signals
| 50-day / 200-day average | 2.247 / 1.876 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.098 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Mar 2020 | NZD 0.0179 |
| 12 Sep 2019 | NZD 0.0112 |
| 8 Mar 2019 | NZD 0.0203 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.